000 01402 a2200397 4500
005 20250512032652.0
264 0 _c19881115
008 198811s 0 0 eng d
022 _a0012-4486
024 7 _a10.1007/BF00154406
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarmor, M F
245 0 0 _aOscillatory potentials as a marker for dopaminergic disease.
_h[electronic resource]
260 _bDocumenta ophthalmologica. Advances in ophthalmology
_cJul 1988
300 _a255-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
650 0 4 _aAnimals
650 0 4 _aBenzazepines
_xpharmacology
650 0 4 _aDark Adaptation
650 0 4 _aDopamine
_xphysiology
650 0 4 _aDopamine Antagonists
650 0 4 _aElectroretinography
650 0 4 _aHumans
650 0 4 _aPhotic Stimulation
_xmethods
650 0 4 _aRabbits
650 0 4 _aReaction Time
650 0 4 _aSchizophrenia
_xdiagnosis
700 1 _aHock, P
700 1 _aSchechter, G
700 1 _aPfefferbaum, A
700 1 _aBerger, P A
700 1 _aMaurice, R
773 0 _tDocumenta ophthalmologica. Advances in ophthalmology
_gvol. 69
_gno. 3
_gp. 255-61
856 4 0 _uhttps://doi.org/10.1007/BF00154406
_zAvailable from publisher's website
999 _c3054756
_d3054756